What Is the JN.1 Variant?

The JN.1 variant is a variant of SARS-CoV-2, the virus that causes COVID-19, and belongs to the Omicron family. JN.1 evolved from the BA.2.86 lineage and was first identified in 2023. Due to its rapid spread, it was closely monitored by the World Health Organization (WHO). Many SARS-CoV-2 variants that emerged later also descended from the JN.1 lineage. 

Symptoms associated with JN.1 are generally similar to those caused by other COVID-19 variants. Fever, cough, sore throat, runny nose, fatigue, headache and muscle aches may occur. The severity of symptoms may vary depending on age, immune status, underlying medical conditions, and previous infection or vaccination.

In this article, we discuss what the JN.1 variant is, its symptoms, how it spreads, how COVID-19 is diagnosed and treated, and what measures can help reduce the risk of infection.

What Is the JN.1 Variant?

JN.1 is a variant of SARS-CoV-2 belonging to the Omicron family. It evolved from the BA.2.86 lineage and carries additional genetic changes in its spike protein. WHO designated JN.1 as a separate Variant of Interest in December 2023. 

JN.1 subsequently spread worldwide and became the genetic foundation for several later SARS-CoV-2 lineages. Some variants circulating in 2026, including XFG and NB.1.8.1, are descendants of the JN.1 lineage.

What Are the Symptoms of the JN.1 Variant?

Possible JN.1 symptoms are generally similar to symptoms associated with other COVID-19 variants.

Common symptoms may include fever or chills, cough, sore throat, runny or stuffy nose, fatigue, headache, muscle or body aches, shortness of breath, changes in taste or smell, nausea, vomiting and diarrhea.

Not everyone experiences the same symptoms. While some people may have mild illness, older adults, immunocompromised individuals and people with certain underlying medical conditions may be at greater risk of developing severe COVID-19.

How Does the JN.1 Variant Spread?

Like other SARS-CoV-2 variants, JN.1 can spread primarily through virus-containing respiratory particles released by an infected person.

Transmission may be more likely in crowded, enclosed or poorly ventilated environments. Close and prolonged contact with an infected person can also increase the risk of infection.

How Is the JN.1 Variant Diagnosed?

PCR and appropriate antigen tests can be used to detect COVID-19 infection. However, a positive standard COVID-19 PCR test does not necessarily identify JN.1 as the specific variant responsible for the infection.

Advanced laboratory methods such as genomic sequencing may be required to determine the exact SARS-CoV-2 variant.

Therefore, it is generally not possible to determine which COVID-19 variant a person has based on symptoms alone.

How Is the JN.1 Variant Treated?

There is no standard treatment specifically designed only for the JN.1 variant that is completely different from the treatment of other COVID-19 infections.

For mild cases, treatment may primarily involve supportive care, including rest, adequate fluid intake and management of symptoms.

For individuals at increased risk of severe COVID-19, antiviral medications or other treatments may be considered following medical evaluation.

Is the JN.1 Variant Dangerous?

Although JN.1 attracted attention because of its rapid spread, increased transmissibility does not necessarily mean that a variant causes more severe disease.

The risk of severe COVID-19 varies depending on factors such as age, immune status and underlying medical conditions.

WHO states that SARS-CoV-2 continues to circulate globally in 2026 and can still cause severe disease, post-COVID-19 condition and death, particularly among vulnerable populations.

Do COVID-19 Vaccines Protect Against the JN.1 Variant?

One of the primary purposes of COVID-19 vaccination is to reduce the risk of severe illness and complications.

COVID-19 vaccine compositions can be updated as SARS-CoV-2 continues to evolve. In May 2026, WHO recommended monovalent LP.8.1 as the preferred vaccine antigen while emphasizing that vaccination should not be delayed while waiting for vaccines with an updated antigen composition.

Whether an individual needs an updated COVID-19 vaccine or additional dose should be determined according to age, individual risk factors, previous vaccination history and current recommendations from local health authorities.

How Can You Reduce the Risk of JN.1 and COVID-19?

Several measures can help reduce the risk of COVID-19 and other respiratory infections, particularly during periods of increased transmission.

Improving ventilation in indoor environments, maintaining good hand hygiene, reducing close contact with others when experiencing symptoms, and using masks when appropriate may help reduce transmission.

People at increased risk of severe COVID-19 should also follow current vaccination recommendations from healthcare authorities and their healthcare professionals.

In Which Countries Was the JN.1 Variant Detected?

JN.1 spread globally after its emergence and was not limited to a specific country or region.

Today, surveillance has increasingly shifted toward newer descendants of the JN.1 lineage. As of July 2026, WHO continues to monitor JN.1-descendant variants such as NB.1.8.1 and XFG. 

When Should You See a Doctor?

COVID-19 can cause mild symptoms in many people, but more serious respiratory problems may develop in some cases.

Urgent medical attention should be sought for symptoms such as severe or worsening shortness of breath, chest pain, bluish discoloration, changes in consciousness or rapid deterioration in general health.

Older adults, immunocompromised individuals and people with chronic medical conditions may benefit from contacting a healthcare professional earlier when COVID-19 symptoms develop.

Get Online Medical Support with Happ Health

With our “Health Everywhere, for Everyone, Always” approach, we believe that proper evaluation of COVID-19 and other respiratory symptoms and early recognition of potentially serious conditions are important.

If you are experiencing fever, cough, sore throat, fatigue or other symptoms associated with COVID-19, you can use Happ Health's Online Enfection Disaese Specialist service to consult a healthcare professional.

Your doctor can evaluate your symptoms, medical history and individual risk factors and provide guidance regarding testing, treatment options and follow-up.